Impact of pre-stroke dependency on outcome after endovascular therapy in acute ischemic stroke
Authors:
Open Access
- 31 August 2020
- journal article
- research article
- Published by Springer Nature in Journal of Neurology
- Vol. 268 (2) , 541-548
Abstract
Background and purpose: Current demographic changes indicate that more people will be care-dependent due to increasing life expectancy. Little is known about impact of preexisting dependency on stroke outcome after endovascular treatment (EVT). Methods: We compared prospectively collected baseline and outcome data of previously dependent vs. independent stroke patients (prestroke modified Rankin Scale score of 3–5 vs. 0–2) treated with EVT. Outcome measures were favorable 3-month outcome (mRS ≤ 3 for previously dependent and mRS ≤ 2 for independent patients, respectively), death and symptomatic intracranial hemorrhage (sICH). Results: Among 1247 patients, 84 (6.7%) were dependent before stroke. They were older (81 vs. 72 years of age), more often female (61.9% vs. 46%), had a higher stroke severity at baseline (NIHSS 18 vs. 15 points), more often history of previous stroke (32.9% vs. 9.1%) and more vascular risk factors than independent patients. Favorable outcome and mortality were to the disadvantage of independent patients (26.2% vs. 44.4% and 46.4% vs. 25.5%, respectively), whereas sICH was comparable in both cohorts (4.9% vs. 5%). However, preexisting dependency was not associated with clinical outcome and mortality after adjusting for outcome predictors (OR 1.076, 95% CI 0.612–1.891; p = 0.799 and OR 1.267, 95% CI 0.758–2.119; p = 0.367, respectively). Conclusion: Our study underscores the need for careful selection of care-dependent stroke patients when considering EVT, given a less favorable outcome observed in this cohort. Nonetheless, EVT should not systematically be withheld in patients with preexisting disability, since prior dependency does not significantly influence outcome.Keywords
Funding Information
- Schweizerische Herzstiftung
- Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung
- Stryker
- Pfizer
- Bayer
This publication has 45 references indexed in Scilit:
- Prestroke Modified Rankin Stroke Scale Has Moderate Interobserver Reliability and Validity in an Acute Stroke SettingStroke, 2012
- Statistical Analysis of the Primary Outcome in Acute Stroke TrialsStroke, 2012
- Factors influencing in-hospital mortality and morbidity in patients treated on a stroke unitNeurology, 2011
- Long-Term Effect of Intra-Arterial Thrombolysis in StrokeStroke, 2006
- Predicting Major Neurological Improvement With Intravenous Recombinant Tissue Plasminogen Activator Treatment of StrokeStroke, 2004
- Baseline Measures and Outcome PredictionsNeuroepidemiology, 1994
- Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in Acute Stroke Treatment.Stroke, 1993
- The frequency, causes and timing of death within 30 days of a first stroke: the Oxfordshire Community Stroke Project.Journal of Neurology, Neurosurgery & Psychiatry, 1990
- Measurements of acute cerebral infarction: a clinical examination scale.Stroke, 1989
- Interobserver agreement for the assessment of handicap in stroke patients.Stroke, 1988